TY  - GEN
AU  - Alvarez-Larrán, Alberto
AU  - Pérez-Encinas, Manuel
AU  - Ferrer-Marín, Francisca
AU  - Hernández-Boluda, Juan Carlos
AU  - Ramírez, María José
AU  - Martinez-Lopez, Joaquin
AU  - Magro, Elena
AU  - Cruz, Yasmina
AU  - Mata, María Isabel
AU  - Aragües, Pilar
AU  - Fox, María Laura
AU  - Cuevas, Beatriz
AU  - Montesdeoca, Sara
AU  - Hernández-Rivas, José Angel
AU  - García-Gutiérrez, Valentín
AU  - Gómez-Casares, María Teresa
AU  - Steegmann, Juan Luis
AU  - Durán, María Antonia
AU  - Gómez, Montse
AU  - Kerguelen, Ana
AU  - Bárez, Abelardo
AU  - García, Mari Carmen
AU  - Boqué, Concepción
AU  - Raya, José María
AU  - Martínez, Clara
AU  - Albors, Manuel
AU  - García, Francesc
AU  - Burgaleta, Carmen
AU  - Besses, Carlos
PY  - 2017
DO  - 10.3324/haematol.2016.152769
SN  - 0390-6078
UR  - http://hdl.handle.net/20.500.12105/7081
AB  - Hematocrit control below 45% is associated with a lower rate of thrombosis in polycythemia vera. In patients receiving hydroxyurea, this target can be achieved with hydroxyurea alone or with the combination of hydroxyurea plus phlebotomies. However,...
LA  - eng
PB  - Fondazione Ferrata Storti
KW  - Factores de Tiempo
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Hydroxyurea
TI  - Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea
TY  - research article
ER  -